Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Rhythm Pharmaceuticals Inc (NQ: RYTM)
32.00 USD  -0.07 (-0.22%)
Official Closing Price  /  Updated: 5:00 PM EDT, Sep 24, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 352,800
Open 31.95
Bid (Size) 12.31 (9)
Ask (Size) 32.00 (1)
Prev. Close 32.07
Today's Range 31.57 - 32.52
52wk Range 16.80 - 37.23
Shares Outstanding 27,530,184
Dividend Yield N/A
Performance
YTD
+14.29%
+14.29%
1 Month
-0.44%
-0.44%
3 Month
-4.33%
-4.33%
6 Month
+51.73%
+51.73%
1 Year
+6.67%
+6.67%
Top News
More News
Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today... Read More
from GlobeNewswire News Releases
New Research: Key Drivers of Growth for Harmonic, Astec Industries, Marlin Business Services, Arsanis, SunOpta, and Rhythm Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Produ
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Harmonic Inc.... Read More
from GlobeNewswire News Releases
More News
Read More
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
from GlobeNewswire News Releases
Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
from GlobeNewswire News Releases
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
from GlobeNewswire News Releases
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
from GlobeNewswire News Releases
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
from GlobeNewswire News Releases
Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
from GlobeNewswire News Releases
Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
from GlobeNewswire News Releases
Factors of Influence in 2018, Key Indicators and Opportunity within BiondVax Pharmaceuticals, MercadoLibre, 1-800 FLOWERS.COM, Redhill Biopharma, Mountain Province Diamonds, and Rhythm Pharmaceuticals
from GlobeNewswire News Releases
Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.